PMID: 2493649Mar 1, 1989Paper

Formation and action of 8-hydroxy-11,12-epoxy-5,9,14-icosatrienoic acid in Aplysia: a possible second messenger in neurons

Proceedings of the National Academy of Sciences of the United States of America
D PiomelliS J Feinmark

Abstract

In Aplysia neural tissue, the release and metabolism of arachidonic acid are stimulated by histamine or by activation of the identified L32 nerve cell circuit of the abdominal ganglion. Previously we found that histamine and intracellular stimulation of L32 cells, which are putatively histaminergic neurons, cause the production of 12-hydroxy-5,8,10,14-icosatetraenoic acid (12-HETE), a product of the 12-lipoxygenase pathway formed through 12-hydroperoxy-5,8,10,14-icosatetraenoic acid (12-HPETE). 12-HPETE, but not 12(S)-HETE, mimics the dual-action response of L14 ink motor neurons to histamine and stimulation of L32. 12-HPETE can also be further metabolized to 8-hydroxy-11,12-epoxy-5,9,14-icosatrienoic acid (8-HEpETE) which was identified by HPLC, enzymatic hydrolysis, and GC/MS. Production of 8-HEpETE is specific, as its positional isomer 10-hydroxy-11,12-epoxy-5,8,14-icosatrienoic acid is not formed after physiologic stimulation. 8-HEpETE can elicit the late component (hyperpolarization) of the dual-action response in L14 cells, suggesting that it may be a second messenger in Aplysia.

References

Feb 20, 1975·Biochimica Et Biophysica Acta·D H Nugteren
Feb 29, 1988·Biochemical and Biophysical Research Communications·C R Pace-Asciak
Sep 1, 1974·Proceedings of the National Academy of Sciences of the United States of America·M Hamberg, B Samuelsson
Dec 1, 1973·Proceedings of the National Academy of Sciences of the United States of America·M EisenstadtJ H Schwartz

❮ Previous
Next ❯

Citations

Oct 1, 1993·Biulleten' eksperimental'noĭ biologii i meditsiny·A S PivovarovG I Miagkova
Sep 1, 1991·Neurochemical Research·L Pellerin, L S Wolfe
Jun 19, 1991·Biochimica Et Biophysica Acta·O LaneuvilleC R Pace-Asciak
Oct 30, 1992·Biochimica Et Biophysica Acta·S Yamamoto
Nov 17, 1994·Biochimica Et Biophysica Acta·C R Pace-Asciak
Sep 1, 1990·Trends in Pharmacological Sciences·D Piomelli, P Greengard
Jan 13, 1992·Biochimica Et Biophysica Acta·K A SheppardC N Serhan
Mar 1, 1991·Brain Research. Molecular Brain Research·A CalignanoJ H Schwartz
Jan 1, 1991·Neurochemistry International·N C SchaadM Schorderet
Jul 1, 1993·General Pharmacology·C R Pace-Asciak
Oct 1, 1995·Journal of Lipid Mediators and Cell Signalling·T Yoshimoto, S Yamamoto
Mar 7, 1998·European Journal of Pharmacology·M NishiyamaT Shimizu
Nov 16, 2002·Prostaglandins & Other Lipid Mediators·Tanihiro Yoshimoto, Yoshitaka Takahashi
Nov 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·D PiomelliP Greengard
Apr 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·C R Pace-AsciakP L Carlen
Apr 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·A MargalitA A Livne
Mar 1, 1993·European Journal of Biochemistry·T WatanabeB Samuelsson
Jun 16, 2009·American Journal of Physiology. Heart and Circulatory Physiology·Yuttana ChawengsubWilliam B Campbell
Feb 5, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Anthony J DeCostanzoSteven A Siegelbaum
Jul 1, 1990·Journal of Neurochemistry·T Shimizu, L S Wolfe
Sep 28, 1990·Biochemical and Biophysical Research Communications·S NigamC R Pace-Asciak
Oct 1, 1994·Prostaglandins, Leukotrienes, and Essential Fatty Acids·L De Petrocellis, V Di Marzo
Aug 30, 1991·Biochemical and Biophysical Research Communications·Z LinC R Pace-Asciak
Dec 31, 1990·Biochemical and Biophysical Research Communications·C R Pace-AsciakE J Corey
Oct 4, 2005·Biochemical and Biophysical Research Communications·Santosh Nigam, Maria-Patapia Zafiriou
Jul 25, 1997·The Journal of Biological Chemistry·D J SteelS J Feinmark
Jan 1, 1989·Annals of the New York Academy of Sciences·S J FeinmarkJ H Schwartz
May 9, 2009·British Journal of Pharmacology·Cecil R Pace-Asciak
Jan 1, 1994·Journal of Neurochemistry·D ReynaudC R Pace-Asciak
May 5, 2004·The Journal of Biological Chemistry·Santosh NigamJesper Z Haeggström

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.